EICHOR
● Active Not Recruiting
Study of DSP-0390 in Patients With Recurrent High-Grade Glioma
Condition: High Grade Glioma · Glioblastoma Multiforme · Sponsor: Sumitomo Pharma America, Inc.
About this study
This is a study of DSP-0390 in patients with recurrent high grade glioma.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (9)
| University of California at San Francisco | San Francisco, California, United States | — |
| Dana Farber Cancer Institute | Boston, Massachusetts, United States | — |
| Washington University School of Medicine | St Louis, Missouri, United States | — |
| John Theurer Cancer Center at Hackensack University Medical Center | Hackensack, New Jersey, United States | — |
| Columbia University | New York, New York, United States | — |
| Huntsman Cancer Institute, University of Utah | Salt Lake City, Utah, United States | — |
| Hokkaido University Hospital | Sapporo, Hokkaido, Japan | — |
| Kyoto University Hospital | Kyoto, Sakyo-ku, Japan | — |
| National Cancer Center Hospital | Chuo Ku, Tokyo, Japan | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05023551